-
1
-
-
84926452265
-
Safety and efficacy outcomes with erythropoiesis-stimulating agents in patients with breast cancer: a meta-analysis
-
Aapro M., Moebus V., Nitz U., O'Shaughnessy J., Pronzato P., Untch M., et al. Safety and efficacy outcomes with erythropoiesis-stimulating agents in patients with breast cancer: a meta-analysis. Ann. Oncol. 2014, 26.
-
(2014)
Ann. Oncol.
, vol.26
-
-
Aapro, M.1
Moebus, V.2
Nitz, U.3
O'Shaughnessy, J.4
Pronzato, P.5
Untch, M.6
-
2
-
-
0028659004
-
Operating characteristics of a rank correlation test for publication bias
-
Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50(4):1008-1101.
-
(1994)
Biometrics
, vol.50
, Issue.4
, pp. 1008-1101
-
-
Begg, C.B.1
Mazumdar, M.2
-
3
-
-
34047179553
-
Hemoglobin variation and blood transfusion rates in patients affected by locally advanced cervical cancer undergoing neo-adjuvant chemotherapy followed by radical surgery: the role of erythropoietic growth factors
-
Bellati F., Pernice M., Manci N., et al. Hemoglobin variation and blood transfusion rates in patients affected by locally advanced cervical cancer undergoing neo-adjuvant chemotherapy followed by radical surgery: the role of erythropoietic growth factors. Ann. Oncol. 2007, 18(4):722-729.
-
(2007)
Ann. Oncol.
, vol.18
, Issue.4
, pp. 722-729
-
-
Bellati, F.1
Pernice, M.2
Manci, N.3
-
4
-
-
40349103260
-
Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia
-
Bennett C.L., Silver S.M., Djulbegovic B., Samaras A.T., Blau C.A., Gleason K.J., et al. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA 2008, 299(8):914-924. 10.1001/jama.299.8.914.
-
(2008)
JAMA
, vol.299
, Issue.8
, pp. 914-924
-
-
Bennett, C.L.1
Silver, S.M.2
Djulbegovic, B.3
Samaras, A.T.4
Blau, C.A.5
Gleason, K.J.6
-
5
-
-
80053628541
-
Randomized phase III trial of sequential adjuvant chemoradiotherapy with or without erythropoietin Alfa in patients with high-risk cervical cancer: results of the NOGGO-AGO intergroup study
-
Blohmer J.U., Paepke S., Sehouli J., Boehmer D., Kolben M., Würschmidt F., et al. Randomized phase III trial of sequential adjuvant chemoradiotherapy with or without erythropoietin Alfa in patients with high-risk cervical cancer: results of the NOGGO-AGO intergroup study. J. Clin. Oncol. 2011, 29(28):3791-3797. 10.1200/JCO.2010.30.4899.
-
(2011)
J. Clin. Oncol.
, vol.29
, Issue.28
, pp. 3791-3797
-
-
Blohmer, J.U.1
Paepke, S.2
Sehouli, J.3
Boehmer, D.4
Kolben, M.5
Würschmidt, F.6
-
6
-
-
65449117261
-
Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials
-
Bohlius J., Schmidlin K., Brillant C., Schwarzer G., Trelle S., Seidenfeld J., et al. Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet 2009, 373(9674):1532-1542. 10.1016/S0140-6736(09)60502-X.
-
(2009)
Lancet
, vol.373
, Issue.9674
, pp. 1532-1542
-
-
Bohlius, J.1
Schmidlin, K.2
Brillant, C.3
Schwarzer, G.4
Trelle, S.5
Seidenfeld, J.6
-
7
-
-
0017977265
-
Definitive evidence for hypoxic cells influencing cure in cancer therapy
-
Bush R.S., Jenkin R.D., Allt W.E., Beale F.A., Bean H., Dembo A.J., Pringle J.F. Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br. J. Cancer Suppl. 1978, 3:302-306.
-
(1978)
Br. J. Cancer Suppl.
, vol.3
, pp. 302-306
-
-
Bush, R.S.1
Jenkin, R.D.2
Allt, W.E.3
Beale, F.A.4
Bean, H.5
Dembo, A.J.6
Pringle, J.F.7
-
8
-
-
0035875880
-
Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review
-
Caro J.J., Salas M., Ward A., Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer 2001, 91(12):2214-2221.
-
(2001)
Cancer
, vol.91
, Issue.12
, pp. 2214-2221
-
-
Caro, J.J.1
Salas, M.2
Ward, A.3
Goss, G.4
-
9
-
-
33749120970
-
Impact of hemoglobin on survival of cervical carcinoma patients treated with concurrent chemoradiotherapy is dependent on lymph node metastasis findings by magnetic resonance imaging
-
Choi Y.S., Yi C.M., Sin J.I., Ye G.W., Shin I.H., Lee T.S. Impact of hemoglobin on survival of cervical carcinoma patients treated with concurrent chemoradiotherapy is dependent on lymph node metastasis findings by magnetic resonance imaging. Int. J. Gynecol. Cancer 2006, 16(5):1846-1854.
-
(2006)
Int. J. Gynecol. Cancer
, vol.16
, Issue.5
, pp. 1846-1854
-
-
Choi, Y.S.1
Yi, C.M.2
Sin, J.I.3
Ye, G.W.4
Shin, I.H.5
Lee, T.S.6
-
10
-
-
0036353024
-
Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery
-
Dunne J.R., Malone D., Tracy J.K., Gannon C., Napolitano L.M. Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery. J. Surg. Res. 2002, 102(2):237-244.
-
(2002)
J. Surg. Res.
, vol.102
, Issue.2
, pp. 237-244
-
-
Dunne, J.R.1
Malone, D.2
Tracy, J.K.3
Gannon, C.4
Napolitano, L.M.5
-
11
-
-
0030922816
-
Bias in meta-analysis detected by a simple, graphical test
-
Egger M., Davey S.G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BJM 1997, 315(7109):629-634.
-
(1997)
BJM
, vol.315
, Issue.7109
, pp. 629-634
-
-
Egger, M.1
Davey, S.G.2
Schneider, M.3
Minder, C.4
-
12
-
-
75549086280
-
Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes
-
Glaspy J., Crawford J., Vansteenkiste J., Henry D., Rao S., Bowers P., et al. Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes. Br. J. Cancer 2010, 102(2):301-315. 10.1038/sj.bjc.6605498.
-
(2010)
Br. J. Cancer
, vol.102
, Issue.2
, pp. 301-315
-
-
Glaspy, J.1
Crawford, J.2
Vansteenkiste, J.3
Henry, D.4
Rao, S.5
Bowers, P.6
-
13
-
-
66149088472
-
Role of recombinant human erythropoietin in patients of advanced cervical cancer treated by chemoradiotherapy
-
Gupta S., Singh P.K., Bisth S.S., Bhatt M.L., Pant M., Gupta R., et al. Role of recombinant human erythropoietin in patients of advanced cervical cancer treated by chemoradiotherapy. Cancer Biol. Ther. 2009, 8(1):13-17.
-
(2009)
Cancer Biol. Ther.
, vol.8
, Issue.1
, pp. 13-17
-
-
Gupta, S.1
Singh, P.K.2
Bisth, S.S.3
Bhatt, M.L.4
Pant, M.5
Gupta, R.6
-
14
-
-
0041627742
-
Efficacy and safety of darbepoetin alfa in anaemic patients with lympho proliferative malignancies: a randomized, double blind, placebo-controlled study
-
Hedenus M., Adriansson M., San Miguel J., Kramer M.H., Schipperus M.R., Juvonen E., et al. Efficacy and safety of darbepoetin alfa in anaemic patients with lympho proliferative malignancies: a randomized, double blind, placebo-controlled study. Br. J. Haematol. 2003, 122(3):394-403.
-
(2003)
Br. J. Haematol.
, vol.122
, Issue.3
, pp. 394-403
-
-
Hedenus, M.1
Adriansson, M.2
San Miguel, J.3
Kramer, M.H.4
Schipperus, M.R.5
Juvonen, E.6
-
15
-
-
0142186283
-
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial
-
Henke M., Laszig R., Rübe C., Haase K.D., Schilcher B., Mose S., et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 2003, 362(9392):1255-1260.
-
(2003)
Lancet
, vol.362
, Issue.9392
, pp. 1255-1260
-
-
Henke, M.1
Laszig, R.2
Rübe, C.3
Haase, K.D.4
Schilcher, B.5
Mose, S.6
-
16
-
-
0142186283
-
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial
-
Henke M., Laszig R., Rübe C., Schäfer U., Haase K.D., Schilcher B., Mose S., Beer K.T., Burger U., Dougherty C., Frommhold H. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 2003, 362(9392):1255-1260.
-
(2003)
Lancet
, vol.362
, Issue.9392
, pp. 1255-1260
-
-
Henke, M.1
Laszig, R.2
Rübe, C.3
Schäfer, U.4
Haase, K.D.5
Schilcher, B.6
Mose, S.7
Beer, K.T.8
Burger, U.9
Dougherty, C.10
Frommhold, H.11
-
17
-
-
0041876133
-
Measuring inconsistency in meta-analyses
-
Higgins J.P.T., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
-
(2003)
BMJ
, vol.327
, pp. 557-560
-
-
Higgins, J.P.T.1
Thompson, S.G.2
Deeks, J.J.3
Altman, D.G.4
-
18
-
-
56749168978
-
Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer
-
Khorana A.A., Francis C.W., Blumberg N., Culakova E., Refaai M.A., Lyman G.H. Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. Arch. Intern. Med. 2008, 168(November (21)):2377-2381. 10.1001/archinte.168.21.2377.
-
(2008)
Arch. Intern. Med.
, vol.168
, Issue.NOVEMBER 21
, pp. 2377-2381
-
-
Khorana, A.A.1
Francis, C.W.2
Blumberg, N.3
Culakova, E.4
Refaai, M.A.5
Lyman, G.H.6
-
19
-
-
0031172237
-
Erythropoietin treatment under polychemotherapy in patients with gynecologic malignancies: a prospective, randomized, double-blind placebo-controlled multicenter study
-
Kurz Ch., Marth Ch., Windbichler G., Lahousen M., Medl M., Vavra N., et al. Erythropoietin treatment under polychemotherapy in patients with gynecologic malignancies: a prospective, randomized, double-blind placebo-controlled multicenter study. Gynecol. Oncol. 1997, 65(3):461-466.
-
(1997)
Gynecol. Oncol.
, vol.65
, Issue.3
, pp. 461-466
-
-
Kurz, C.1
Marth, C.2
Windbichler, G.3
Lahousen, M.4
Medl, M.5
Vavra, N.6
-
20
-
-
24944454286
-
Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study
-
Leyland-Jones B., Semiglazov V., Pawlicki M., Pienkowski T., Tjulandin S., Manikhas G., et al. Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study. J. Clin. Oncol. 2005, 23(25):5960-5972.
-
(2005)
J. Clin. Oncol.
, vol.23
, Issue.25
, pp. 5960-5972
-
-
Leyland-Jones, B.1
Semiglazov, V.2
Pawlicki, M.3
Pienkowski, T.4
Tjulandin, S.5
Manikhas, G.6
-
21
-
-
44149085240
-
Nasopharynx
-
Lippincott Williams & Wilkins, 2013, (Chapter 41), E.C. Halperin, L.W. Brady, C.A. Perez, D.E. Wazer (Eds.)
-
Lok B.H., Setton J., Ho F., Riaz N., Rao S.S., Lee N.Y. Nasopharynx. Perez & Brady's Principles and Practice of Radiation Oncology 2015, 730-759. Lippincott Williams & Wilkins, 2013, (Chapter 41). 6th ed. E.C. Halperin, L.W. Brady, C.A. Perez, D.E. Wazer (Eds.).
-
(2015)
Perez & Brady's Principles and Practice of Radiation Oncology
, pp. 730-759
-
-
Lok, B.H.1
Setton, J.2
Ho, F.3
Riaz, N.4
Rao, S.S.5
Lee, N.Y.6
-
22
-
-
5344263788
-
The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients
-
Ludwig H., Van Belle S., Barrett-Lee P., Birgegård G., Bokemeyer C., Gascón P., et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur. J. Cancer 2004, 40(15):2293-2306.
-
(2004)
Eur. J. Cancer
, vol.40
, Issue.15
, pp. 2293-2306
-
-
Ludwig, H.1
Van Belle, S.2
Barrett-Lee, P.3
Birgegård, G.4
Bokemeyer, C.5
Gascón, P.6
-
23
-
-
67649934442
-
Pooled analysis of individual patient-level data from all randomized, double-blind, placebo-controlled trials of darbepoetin alfa in the treatment of patients with chemotherapy-induced anemia
-
Ludwig H., Crawford J., Osterborg A., Vansteenkiste J., Henry D.H., Fleishman A., et al. Pooled analysis of individual patient-level data from all randomized, double-blind, placebo-controlled trials of darbepoetin alfa in the treatment of patients with chemotherapy-induced anemia. J. Clin. Oncol. 2009, 27(17):2838-2847. 10.1200/JCO.2008.19.1130.
-
(2009)
J. Clin. Oncol.
, vol.27
, Issue.17
, pp. 2838-2847
-
-
Ludwig, H.1
Crawford, J.2
Osterborg, A.3
Vansteenkiste, J.4
Henry, D.H.5
Fleishman, A.6
-
24
-
-
84862524935
-
Erythropoietin: the swinging pendulum
-
Oster H.S., Neumann D., Hoffman M., Mittelman M. Erythropoietin: the swinging pendulum. Leuk. Res. 2012, 36(8):939-944. 10.1016/j.leukres.2012.04.017.
-
(2012)
Leuk. Res.
, vol.36
, Issue.8
, pp. 939-944
-
-
Oster, H.S.1
Neumann, D.2
Hoffman, M.3
Mittelman, M.4
-
25
-
-
0031909654
-
A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85
-
Overgaard J., Hansen H.S., Overgaard M., Bastholt L., Berthelsen A., Specht L., Lindeløv B., Jørgensen K. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiother. Oncol. 1998, 46(2):135-146.
-
(1998)
Radiother. Oncol.
, vol.46
, Issue.2
, pp. 135-146
-
-
Overgaard, J.1
Hansen, H.S.2
Overgaard, M.3
Bastholt, L.4
Berthelsen, A.5
Specht, L.6
Lindeløv, B.7
Jørgensen, K.8
-
26
-
-
84862511438
-
Randomized study of the importance of novel erythropoiesis stimulating protein (Aranesp) for the effect of radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC). The Danish Head and Neck Cancer Group DAHANCA 10 [abstract 6LB]
-
Overgaard J., Hoff C., San Hansen H., et al. Randomized study of the importance of novel erythropoiesis stimulating protein (Aranesp) for the effect of radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC). The Danish Head and Neck Cancer Group DAHANCA 10 [abstract 6LB]. Eur. J. Cancer 2007, 7.
-
(2007)
Eur. J. Cancer
, vol.7
-
-
Overgaard, J.1
Hoff, C.2
San Hansen, H.3
-
27
-
-
41949140285
-
Darbepoetin alpha for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study
-
Smith R.E., Aapro M.S., Ludwig H., Pintér T., Smakal M., Ciuleanu T.E., et al. Darbepoetin alpha for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study. J. Clin. Oncol. 2008, 26(7):1040-1050. 10.1200/JCO.2007.14.2885.
-
(2008)
J. Clin. Oncol.
, vol.26
, Issue.7
, pp. 1040-1050
-
-
Smith, R.E.1
Aapro, M.S.2
Ludwig, H.3
Pintér, T.4
Smakal, M.5
Ciuleanu, T.E.6
-
28
-
-
40549107811
-
Effects of anemia correction with epoetin beta in patients receiving radiochemotherapy for advanced cervical cancer
-
Strauss H.G., Haensgen G., Dunst J., Hayward C.R., Burger H.U., Scherhag A., et al. Effects of anemia correction with epoetin beta in patients receiving radiochemotherapy for advanced cervical cancer. Int. J. Gynecol. Cancer 2008, 18(3):515-524.
-
(2008)
Int. J. Gynecol. Cancer
, vol.18
, Issue.3
, pp. 515-524
-
-
Strauss, H.G.1
Haensgen, G.2
Dunst, J.3
Hayward, C.R.4
Burger, H.U.5
Scherhag, A.6
-
29
-
-
38649128164
-
Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0g/dL with erythropoietin vs above 10.0g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer
-
Thomas G., Ali S., Hoebers F.J., Rodgers W.H., Patel M., Abulafia O., et al. Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0g/dL with erythropoietin vs above 10.0g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer. Gynecol. Oncol. 2008, 108(2):317-325.
-
(2008)
Gynecol. Oncol.
, vol.108
, Issue.2
, pp. 317-325
-
-
Thomas, G.1
Ali, S.2
Hoebers, F.J.3
Rodgers, W.H.4
Patel, M.5
Abulafia, O.6
-
30
-
-
34547450763
-
Practical methods for incorporating summary time-to-event data into meta-analysis
-
Tierney J.F., Stewart L.A., Ghersi D., Burdett S., Sydes M.R. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007, 8:16.
-
(2007)
Trials
, vol.8
, pp. 16
-
-
Tierney, J.F.1
Stewart, L.A.2
Ghersi, D.3
Burdett, S.4
Sydes, M.R.5
-
31
-
-
80052401850
-
PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin-cyclophosphamide followed by paclitaxel with or without dar- bepoetin alfa in primary breast cancer-outcome on prognosis
-
Untch M., von Minckwitz G., Konecny G.E., von Koch F., Conrad U., Fett W., et al. PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin-cyclophosphamide followed by paclitaxel with or without dar- bepoetin alfa in primary breast cancer-outcome on prognosis. Ann. Oncol. 2011, 22(9):1999-2006. 10.1093/annonc/mdq709.
-
(2011)
Ann. Oncol.
, vol.22
, Issue.9
, pp. 1999-2006
-
-
Untch, M.1
von Minckwitz, G.2
Konecny, G.E.3
von Koch, F.4
Conrad, U.5
Fett, W.6
-
32
-
-
84860542278
-
Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: study-level and patient-level meta-analyses
-
Vansteenkiste J., Glaspy J., Henry D., Ludwig H., Pirker R., Tomita D., et al. Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: study-level and patient-level meta-analyses. Lung Cancer 2012, 76(3):478-485. 10.1016/j.lungcan.2011.12.015.
-
(2012)
Lung Cancer
, vol.76
, Issue.3
, pp. 478-485
-
-
Vansteenkiste, J.1
Glaspy, J.2
Henry, D.3
Ludwig, H.4
Pirker, R.5
Tomita, D.6
-
33
-
-
33645750210
-
EPO-INT-45 Study Group Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial
-
Wilkinson P.M., Antonopoulos M., Lahousen M., Lind M., Kosmidis P. EPO-INT-45 Study Group Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial. Br. J. Cancer 2006, 94(7):947-954.
-
(2006)
Br. J. Cancer
, vol.94
, Issue.7
, pp. 947-954
-
-
Wilkinson, P.M.1
Antonopoulos, M.2
Lahousen, M.3
Lind, M.4
Kosmidis, P.5
-
34
-
-
34047221511
-
Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia
-
Wright J.R., Ung Y.C., Julian J.A., Pritchard K.I., Whelan T.J., Smith C., et al. Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia. J. Clin. Oncol. 2007, 25(9):1027-1032.
-
(2007)
J. Clin. Oncol.
, vol.25
, Issue.9
, pp. 1027-1032
-
-
Wright, J.R.1
Ung, Y.C.2
Julian, J.A.3
Pritchard, K.I.4
Whelan, T.J.5
Smith, C.6
-
35
-
-
0031766238
-
Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy
-
ten Bokkel Huinink W.W., de Swart C.A., van Toorn D.W., Morack G., Breed W.P., Hillen H.F., et al. Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy. Med. Oncol. 1998, 15(3):174-182.
-
(1998)
Med. Oncol.
, vol.15
, Issue.3
, pp. 174-182
-
-
ten Bokkel Huinink, W.W.1
de Swart, C.A.2
van Toorn, D.W.3
Morack, G.4
Breed, W.P.5
Hillen, H.F.6
|